Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | -0.49% |
|
+1.50% | -13.40% |
24/06 | Transcript : Aprea Therapeutics, Inc. - Special Call | |
17/06 | Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051 | CI |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- MarketScreener Strategies